NICOLAS JONES: Open Payments
NPI 1740058221 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,182 in 94 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,674 · 2025 $2,182
Food & beverage: $2,097Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $455 |
| Janssen Biotech, Inc. | 8 | $317 |
| Ardelyx, Inc. | 10 | $263 |
| Madrigal Pharmaceuticals | 7 | $161 |
| PFIZER INC. | 8 | $159 |
| Lilly USA, LLC | 8 | $149 |
| Aimmune Therapeutics, Inc. | 6 | $113 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $107 |
| Novo Nordisk Inc | 1 | $104 |
| Gilead Sciences, Inc. | 4 | $102 |
Products named: TREMFYA, IBSRELA, RINVOQ, SKYRIZI, REZDIFFRA, OMVOH, ZENPEP, XIFAXAN.
Industry payments across NC — which companies pay providers there.
